- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03844607
Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury
Study Overview
Status
Conditions
Detailed Description
Behavioral changes following a traumatic brain injury (TBI) are one of the biggest challenges for patients, as well as their family members and others involved in their recovery. One of the most common behavioral changes following TBI is the emergence of impulsive behavior, which has been associated with destructive, suicidal, and aggressive behavior, and is related to poor rehabilitation program adherence. The primary objective of this study is to investigate the effect of a novel neuroplasticity based intervention approach utilizing transcranial direct current stimulation (tDCS) to alter brain neuroplasticity combined with cognitive training tasks selected to functionally target cognition and brain circuits that are impaired in those TBI patients with impulsive behavior.
This double-blind, randomized, placebo (sham) controlled study will recruit 30 Veterans with a history of mild, moderate or severe TBI, who exhibit a variety of impulsive behaviors. Participants will be randomly assigned to receive either active or sham tDCS, both paired with cognitive training tasks, once a day for five days. Additionally, participants will attend three follow up visits at 1, 2, and 3 months after the course of intervention visits is completed. Functional magnetic resonance imaging (fMRI) will be collected before and after intervention, to measure brain activity changes across time depending on intervention type.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55417
- Minneapolis VA Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Participants will be included in the study if they:
- have a clinical history of impulsive behavior, including substance abuse, gambling problems, legal issues such as DUI, violent acts, aggression, history of suicidality, or ADHD as assessed by the patient's clinical provider and/or screen of medical records
- are age 18 or older
- are receiving services from the Minneapolis VA Health Care System
- are stable on any medications for at least 1 week at the baseline visit
- have a diagnosis of mild, moderate, or severe TBI (as defined by VA/DoD Clinical Practice Guidelines criteria)
Exclusion Criteria:
Persons will be excluded from this study if they:
- have a significant neurological disorder based on the Principal Investigators judgment that would impact risk
- diagnosed with current active psychosis or mania
- have metallic cranial plates/screws or implanted devices
- have eczema on scalp or other scalp lesions or skin disorders that may become irritated by stimulation
- are pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Active tDCS
Participants will receive 5 sessions of cognitive training concurrent with transcranial direct current stimulation (anode over left frontal cortex, cathode over right frontal cortex; 2 mAmps for 20 minutes).
|
Cognitive training concurrent with 2 mAmps of anodal stimulation applied to the left frontal cortex for 20 minutes.
|
|
Sham Comparator: Sham tDCS
Participants will receive 5 sessions of cognitive training concurrent with sham tDCS.
For sham tDCS, electrodes are placed at the same locations as for active tDCS, but current is ramped up for the initial 30 secs, then immediately ramped back down.
This method mimics the initial physical sensation of stimulation, but there is no active current for the remainder of the session.
|
Cognitive training concurrent with sham tDCS (30 secs ramp up/ramp down of current at beginning of session).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Barratt Impulsiveness Scale (BIS)
Time Frame: Change between baseline and 1 week follow-up; 1, 2, and 3 months following intervention
|
Differences in magnitude of change in BIS scores between active tDCS and sham groups from baseline to follow-up sessions.
Higher total score on the BIS indicates higher levels of impulsivity.
|
Change between baseline and 1 week follow-up; 1, 2, and 3 months following intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in choice of higher risk option in the Risk Task
Time Frame: Change between baseline and 1 week follow-up; 1, 2, and 3 months following intervention
|
Differences in magnitude of change in choice of higher risk option during the Risk Task between active tDCS and sham groups from baseline to follow-up sessions.
Greater choice of higher risk options in the Risk Task indicates higher levels of risk-taking and impulsivity.
|
Change between baseline and 1 week follow-up; 1, 2, and 3 months following intervention
|
|
Change in Brain Functional Connectivity as measured by functional magnetic resonance imaging (fMRI)
Time Frame: Change between baseline and 1 week follow-up
|
Compare magnitude of change in frontal-striatal functional connectivity between active tDCS and sham groups from baseline to following the 5 sessions of intervention.
|
Change between baseline and 1 week follow-up
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VAM-18-00308
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Traumatic Brain Injury
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Hospital Sirio-LibanesUniversity of Sao Paulo; Ministry of Health, Brazil; Hospital Sao Rafael; PROAD... and other collaboratorsRecruitingBrain Injury Traumatic Severe | Brain Injury Traumatic Moderate | Post Traumatic EpilepsyBrazil
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueRecruitingTBI (Traumatic Brain Injury)France
-
Children's Hospital Medical Center, CincinnatiUniversity of CincinnatiCompletedBrain Injury Traumatic MildUnited States
-
University of Texas Southwestern Medical CenterAlbert Einstein College of Medicine; National Institute of Neurological Disorders... and other collaboratorsRecruitingTBI (Traumatic Brain Injury) | TBI | Traumatic Brain Injury With Loss of Consciousness | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateUnited States
-
BrainScope Company, Inc.Active, not recruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States
-
Toronto Rehabilitation InstituteCentre for Aging and Brain Health Innovation; Ontario Neurotrauma FoundationRecruitingBrain Injuries, Traumatic | Brain Injury, Chronic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateCanada
-
University of Sao Paulo General HospitalUnknownTraumatic Brain Injury | Severe Brain Injury | Closed Traumatic Brain InjuryBrazil
-
Queen Mary University of LondonCompleted
Clinical Trials on Active Transcranial Direct Current Stimulation (tDCS)
-
Manhattan Psychiatric CenterCompletedSchizophrenia | Auditory HallucinationUnited States
-
ElsanRecruitingCancer Pain | Refractory PainFrance
-
NYU Langone HealthNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingDepressionUnited States
-
United States Army Aeromedical Research LaboratoryCompletedTranscranial Direct Current StimulationUnited States
-
Washington University School of MedicineCompletedAnxiety | Depressive Symptoms | Cognitive Impairment, MildUnited States
-
Federal University of São PauloSpaulding Rehabilitation HospitalCompletedChronic Pain | Osteoarthritis, KneeBrazil
-
D'Or Institute for Research and EducationCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsCompleted
-
Centre Hospitalier St AnneNot yet recruiting
-
University of BernRecruiting
-
Arcadia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingQuadriceps Muscle Function | Anterior Cruciate Ligament Reconstruction RehabilitationUnited States